Target intelligence / Profile preview

Salmonella enterica serovar Paratyphi A O-specific polysaccharide (SPA OSP) (SPA OSP)

Target
SPA OSP
Molecular classification
Bacterial surface antigen, Polysaccharide, Other
01

Overview

The Salmonella enterica serovar Paratyphi A O-specific polysaccharide is the immunodominant surface antigen of the Gram-negative bacterium responsible for paratyphoid fever, a systemic enteric disease. It constitutes the distal portion of the lipopolysaccharide (LPS) molecule and is composed of repeating tetrasaccharide units characterized by the presence of paratose, which confers the O:2 serotype specificity. This polysaccharide is essential for bacterial survival within the host, as it provides a physical barrier against the host's complement system and other innate immune defenses. Because the purified polysaccharide alone is poorly immunogenic in children, it is typically developed as a conjugate vaccine by linking it to carrier proteins like tetanus toxoid (SPA-TT) to elicit a T-cell dependent immune response. These vaccines are designed to generate high-affinity IgG antibodies that promote opsonophagocytosis and bacterial clearance, offering a strategy to combat the rising threat of multidrug-resistant Paratyphi A strains.

Other names
Paratyphi A O-antigenSPA O-polysaccharideO:2 antigenSalmonella Paratyphi A lipopolysaccharide O-side chainO:2 polysaccharide
02

Mechanism of action

Induction of O-antigen-specific bactericidal IgG antibodies to provide active immunity against Salmonella Paratyphi A infection.

03

Biological functions

Immune responseOther
04

Disease associations

Infection
05

Safety considerations

Injection site reactionsHypersensitivity to carrier proteinsPotential for interference with other conjugate vaccines
06

Interacting drugs

Salmonella Paratyphi A O-specific polysaccharide-tetanus toxoid conjugate

1 more in the full profile.

07

Biomarkers

Anti-O:2 IgG antibody titerSerum bactericidal activity (SBA)

Source types: Peer-reviewed publication. Sources are available to Gosset users. Log in to see them.

Beyond the preview

Go deeper on Salmonella enterica serovar Paratyphi A O-specific polysaccharide (SPA OSP) (SPA OSP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Salmonella enterica serovar Paratyphi A O-specific polysaccharide (SPA OSP) (SPA OSP).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call